EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase

Julia Schönfeld, Steffen Brunst, Ludmila Ciomirtan, Lena Willmer, Michel A Chromik, Adarsh Kumar, Timo Froemel, Nick Liebisch, Arne Hackspacher, Johanna H M Ehrler iD, Lukas Wintermeier, Christina Hesse und 19 weitere

Journal of Medicinal Chemistry · 10.07.2025 · 68 (13) · 13728-13749

DOI: 10.1021/acs.jmedchem.5c00552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.06.2025. Verfasst von Julia Schönfeld und 30 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Chemistry, Goethe University, 60438 Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Epoxide Hydrolases, Drug Design, Enzyme Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fraunhofer Cluster of Excellence Immune-Mediated Diseases, Deutsche Forschungsgemeinschaft, Deutsche Krebshilfe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The bifunctional soluble epoxide hydrolase (sEH) represents a promising target for inflammation-related diseases. Although potent inhibitors targeting each domain are available, sEH-PROTACs offer the unique ability to simultaneously block both enzymatic functions, mimicking the sEH knockout phenotype, which has been associated with reducing inflammation, including neuroinflammation, and delaying the progression of Alzheimer's disease. Herein, we report the structure-based development of a potent sEH-PROTAC as a useful pharmacological tool. In order to facilitate a rapid testing of the PROTACs, a cell-based sEH degradation assay was developed utilizing HiBiT technology. We designed and synthesized 24 PROTACs. Furthermore, cocrystallization of sEH with two selected PROTACs allowed us to explore the binding mode and rationalize the most optimal linker length. After comprehensive biological and physicochemical characterization of this series, the most optimal PROTAC 23 was identified in primary human and murine cells, highlighting the potential of using 23 in disease-relevant cell and tissue models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epoxide HydrolasesDrug DesignEnzyme InhibitorsHumansAnimalsMiceStructure-Activity RelationshipSolubilityProteolysis Targeting Chimera

Substanzen

Epoxide HydrolasesEnzyme InhibitorsProteolysis Targeting Chimera

Autor:innen und Institutionen

  • Institute of Pharmaceutical Chemistry, Goethe University, 60438 Frankfurt am Main, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 60596 Frankfurt am Main, Germany.
  • Institute of Pharmaceutical Biology, Goethe University, 60438 Frankfurt am Main, Germany.
  • Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Member of Fraunhofer Cluster Immune Mediated Diseases (CIMD), 60596 Frankfurt am Main, Germany.
  • Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), 30625 Hannover, Germany.
  • Chair of Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, 42119 Wuppertal, Germany.

ORCID-Profile: Johanna H M Ehrler, Jan Heering, Nils H Schebb, Aimo Kannt, Stefan Knapp, Ewgenij Proschak, Kerstin Hiesinger

Förderung

  • Fraunhofer Cluster of Excellence Immune-Mediated Diseases
  • Deutsche Forschungsgemeinschaft
  • Deutsche Krebshilfe

Zitieren

APA

Schönfeld, J., Brunst, S., Ciomirtan, L., Willmer, L., Chromik, M. A., Kumar, A., Froemel, T., Liebisch, N., Hackspacher, A., Ehrler, J. H. M., Wintermeier, L., Hesse, C., Fiedler, J., Heering, J., Freitag, H., Zardo, P., Fieguth, H. G., Brüggerhoff, A., Jakob, J., …, & Hiesinger, K. (2025). Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase. Journal of Medicinal Chemistry, 68(13), 13728-13749. https://doi.org/10.1021/acs.jmedchem.5c00552

Vancouver

Schönfeld J, Brunst S, Ciomirtan L, Willmer L, Chromik MA, Kumar A, et al. Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase. Journal of Medicinal Chemistry. 2025;68(13):13728-13749. doi:10.1021/acs.jmedchem.5c00552

BibTeX
@article{Schnfeld2025,
  author = {Schönfeld, Julia and Brunst, Steffen and Ciomirtan, Ludmila and Willmer, Lena and Chromik, Michel A and Kumar, Adarsh and Froemel, Timo and Liebisch, Nick and Hackspacher, Arne and Ehrler, Johanna H M and Wintermeier, Lukas and Hesse, Christina and Fiedler, Jan and Heering, Jan and Freitag, Hinrich and Zardo, Patrick and Fieguth, Hans-Gerd and Brüggerhoff, Astrid and Jakob, Josefine and Häupl, Björn and Weizel, Lilia and Kaiser, Astrid and Schubert-Zsilavecz, Manfred and Oellerich, Thomas and Fleming, Ingrid and Schebb, Nils H and Fürst, Robert and Kannt, Aimo and Knapp, Stefan and Proschak, Ewgenij and Hiesinger, Kerstin},
  title = {Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {13},
  pages = {13728--13749},
  doi = {10.1021/acs.jmedchem.5c00552}
}
Kostenlos starten →